Tenax Therapeutics Inc. held its 2025 annual meeting of stockholders on June 11, 2025. During the meeting, several proposals were voted upon. The stockholders elected June Almenoff, Michael Davidson, Declan Doogan, Christopher T. Giordano, Robyn M. Hunter, Gerald T. Proehl, and Stuart Rich to the Board of Directors. The Officer Exculpation Amendment was approved, adding provisions to the Certificate of Incorporation exculpating certain officers from liability in specific circumstances. However, the proposed amendments requiring all stockholder action to be taken at an annual or special meeting were not approved.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。